BEWARE...SOME DAYS ARE NOT VERY PRETTY. I GET CRABBY LIKE NORMAL PEOPLE DO. AND I DO SPEAK MY MIND.
DO NOT READ IF YOU ARE SENSITIVE TO TRUE, REAL, EVERYDAY FEELINGS LIKE MINE.(But I think you would enjoy it)
DON'T FORGET...FREEDOM OF SPEECH !
(and what other INTERNAL side effects will there be?
Just think....what could be going on in your body now and in years to come.)
19-Year-Old’s Breasts Balloon from B Cup to Triple G After Pfizer COVID-19 Vaccine — Researchers Call It First-of-its-Kind Case
by Jim Hᴏft324 CommentsPhoto credit: depositphotos.com
Researchers from the University of Toronto have documented a rare
instance of gigantomastia—abnormal and excessive breast growth—following
the administration of the Pfizer COVID-19 vaccine.
A 19-year-old woman, previously healthy with no notable medical
history, experienced rapid breast enlargement just one week after
receiving her first dose of the Pfizer COVID-19 vaccine in September
2022.
Her condition worsened following the second dose, with her breast
size increasing dramatically from a B cup to a triple G over six months.
Social media users have dubbed this unusual case the “Pfizer Boob Job.”
Preoperative
image of patient with triple G cup breasts following development of macromastia after administration of Pfizer COVID-19 vaccine.Image of patient 5 months postreduction mammoplasty, now with double D breasts.
Despite undergoing extensive medical evaluations, no hormonal abnormalities or other causes were identified.
Doctors determined that the woman’s symptoms aligned with
pseudoangiomatous stromal hyperplasia (PASH), a rare condition involving
idiopathic fibrous mammary tissue growth.
The association between PASH and vaccine administration has not been
previously established, making this case particularly noteworthy.
According to the medical journal:
This case presents a healthy young woman with rapid
bilateral breast enlargement 1 week following Pfizer COVID-19 vaccine
administration. After ruling out other potential causes, she underwent
bilateral reduction mammoplasty, with histology revealing dense terminal
duct lobular units interspersed with PASH.
The patient believed that the vaccine caused her breast
growth; however, her concerns were not adequately addressed by her
primary care physicians, leading to mistrust in the healthcare system.
After multiple specialist consultations and unsuccessful
medication trials, she underwent definitive surgical treatment. Although
a temporal relationship does not establish causality, dismissing
patient concerns can erode trust. Physicians should consider and value
patient concerns when developing therapeutic relationships.
PASH-associated gigantomastia is rare, with fewer than 20
documented cases. Current gigantomastia classification systems do not
account for PASH as an etiological factor and lack detail on the
timeline of breast growth or the type of tissue involved. Including
these elements could improve clinical decision-making and streamline
management.
Further research is needed to develop a comprehensive
classification system for gigantomastia that assists in treatment
planning and a deepens understanding of PASH.
CONCLUSIONS
The cause of gigantomastia remains unclear. Here, we
present the case of a healthy female patient who experienced rapid
breast enlargement, progressing from a B cup to a triple G cup over 6
months, beginning 1 week following Pfizer COVID-19 vaccination.
She underwent bilateral reduction mammoplasty, complicated
by intraoperative bleeding, necessitating postoperative transfusions.
Surgical specimens confirmed PASH. Further research is needed to
understand PASH etiology, refine gigantomastia classification, and
explore the potential link between the Pfizer vaccine, gigantomastia,
and PASH.
FDA-Led Peer-Reviewed
Study by High School Students Uncovers Alarming DNA Contamination in
Pfizer’s mRNA COVID-19 Vaccine at FDA’s Own Lab
by Jim Hᴏft0 CommentsPhoto credit: depositphotos.com
A group of high school students from Centreville High School in
Virginia, in collaboration with the FDA, has uncovered alarming DNA
contamination in both Pfizer’s experimental and commercial mRNA COVID-19
shots.
Their peer-reviewed study, published in the Journal of High School Science on December 29th, has sparked renewed debate over vaccine manufacturing standards and quality control processes.
The researchers, led by Tyler Wang, Alex Kim, and Kevin Kim,
developed a novel method to detect replication-competent DNA impurities
at FDA’s own research facility at the White Oak Campus, Children’s Health Defense reported.
Their technique involves extracting DNA from vaccine samples, ligating it into a circular form, and then transforming it into Escherichia coli cells.
If
transformation results in antibiotic-resistant bacterial colonies, it
indicates the presence of replication-competent DNA, which should
ideally be absent or minimal in the final vaccine product.
The findings were based on analyses of two separate lots of Pfizer’s
mRNA vaccines, including monovalent and bivalent formulations.
The students uncovered significant levels of DNA contamination in the
vaccines, with some samples exceeding the WHO threshold by up to 470
times, the amount of residual DNA detected ranged between 40 to 110
nanograms per dose.
While no replication-competent DNA was detected in commercial Pfizer
vaccine batches, smaller DNA fragments—approximately 35 base pairs in
length—were consistently present.
Interestingly, the study reported sporadic instances of
replication-competent DNA in an in-house mRNA vaccine and a biosimilar
vaccine.
Investigative medical reporter, Maryanne Demasi, Ph.D. first reported:
Kevin McKernan, a former director of the Human Genome
Project, described the findings as a “bombshell,” criticising the FDA
for its lack of transparency.
“These findings are significant not just for what they reveal but for
what they suggest has been concealed from public scrutiny. Why has the
FDA kept these data under wraps?” McKernan questioned.
While commending the students’ work, he also noted limitations in the
study’s methods, which may have underestimated contamination levels.
“The Qubit analysis can under-detect DNA by up to 70% when enzymes
are used during sample preparation,” McKernan explained. “Additionally,
the Plasmid Prep kit used in the study does not efficiently capture
small DNA fragments, further contributing to underestimation.”
[…]
Nikolai Petrovsky, a Professor of Immunology and director of Vaxine Pty Ltd, described the findings as a “smoking gun.”
“It clearly shows the FDA was aware of these data. Given that these
studies were conducted in their own labs under the supervision of their
own scientists, it would be hard to argue they were unaware,” he said.
Prof Petrovsky praised the quality of work carried out by the students at the FDA labs.
“The irony is striking,” he remarked. “These students performed
essential work that the regulators failed to do. It’s not overly
complicated—we shouldn’t have had to rely on students to conduct tests
that were the regulators’ responsibility in the first place.”
It can be recalled that in 2023, Florida Surgeon General, Dr. Joseph
A. Ladapo, demanded answers from Dr. Robert M. Califf, the Commissioner
of the U.S. Food and Drug Administration (FDA), regarding the detection of host cell DNA fragments in mRNA COVID-19 vaccines developed by Pfizer and Moderna.
The Florida Surgeon General sent a letter to
FDA Commissioner Califf and CDC Director Mandy Cohen on December 6,
pressing for greater transparency about the potential for DNA
integration into the human genome—a concern that could have far-reaching
implications.
Ladapo raised alarms about potential nucleic acid contaminants in the
Pfizer and Moderna COVID-19 mRNA vaccines, particularly those in
combination with lipid nanoparticles and the identified Simian Virus 40
(SV40) promoter/enhancer DNA.
“Lipid nanoparticles are an efficient vehicle for delivery of the
mRNA in the COVID-19 vaccines into human cells, and may therefore be an
equally efficient vehicle for delivering contaminant DNA into human
cells. The presence of SV40 promoter/enhancer DNA may also pose a unique
and heightened risk of DNA integration into host cells,” wrote in the
letter.
The Gateway Pundit reported in 2022 that researchers in Sweden published an alarming study showing that Pfizer’s mRNA Covid vaccine can modify DNA within the human genome.
The study,
which was published in the Journal of Clinical Medicine (MDPI), found
that the SARS-CoV-2 RNA within the Pfizer vaccine can reverse-transcribe
itself and install itself within the DNA of the human genome within a
matter of just six hours following exposure to the vaccine.
Aside from the self-explanatory issues of modifying DNA in humans
without their knowledge, the changes can cause “genotoxic side effects,”
according to the study.
From the study,
titled “Intracellular Reverse Transcription of Pfizer BioNTech COVID-19
mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line:”
“Our study shows that BNT162b2 can be reverse transcribed to DNA
in liver cell line Huh7, and this may give rise to the concern
if BNT162b2-derived DNA may be integrated into the host genome and
affect the integrity of genomic DNA, which may potentially mediate
genotoxic side effects.”
Researchers determined that
the mRNA concoction is able to enter the human cell lining at “high
efficiency” after observing the phenomenon happen within human liver
cells in vitro (a lab setting). They detected “high levels” of the
foreign DNA within the liver cell after just a few hours. There were
also rapid changes in gene expression within the affected cells.
